BCM
KYTH

BlueCrest Capital Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

BlueCrest Capital Management’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-80,681
Closed -$6.05M – 1361
2015
Q3 		$6.05M Buy
80,681
+24,854
+45% +$1.86M 0.2% 82
2015
Q2 		$4.2M Buy
+55,827
New +$2.99M 0.12% 173

BlueCrest Capital Management's KYTH Position: Q4 2015 in Review

BlueCrest Capital Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 80,681 shares — an estimated $6.05M sold.

BlueCrest Capital Management first reported a position in KYTH in Q2 2015 and held it in 2 quarters. The position peaked at $6.05M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • BlueCrest Capital Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • BlueCrest Capital Management sold 80,681 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $6.05M.
  • BlueCrest Capital Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2015 and held it in 2 quarters.
  • BlueCrest Capital Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $6.05M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on BlueCrest Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.